Laird Norton Wetherby Trust Company, LLC
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 723204
Seattle, WA
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,035,905
-$77,475 QoQ
Shares Held
2,635
-3.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 4.364326375711575.ToString("F0")%
Shared 0.ToString("F0")%
None 95.63567362428842.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Laird Norton Wetherby Trust Company, LLC holds $17,378,255 across 18 Biotechnology names. REGN ranks #2 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,890 | $5,309,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,635 | $2,035,905 | |
| 3 | ARGX |
Argenx SE
|
2,114 | $1,543,747 | |
| 4 | ANIX |
Anixa Biosciences Inc
|
566,327 | $1,461,123 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,507 | $1,160,360 | |
| 6 | RPRX |
Royalty Pharma plc
|
19,610 | $940,691 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
6,805 | $661,785 | |
| 8 | INCY |
Incyte Corp
|
6,944 | $653,569 |
All Filings in REGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,035,905 | 2,635 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,113,380 | 2,738 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||